J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer
"New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial
University Hospital Heidelberg, Germany
Micro fluid device to avoid painful biopsy of patients with myeloma
New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity
Watch Out For The Me Better 'Trap' Behind The Changing Future Of Frα Adc Rising Stars
